|Articles|February 22, 2017
iCardiac Launches New eCOA Platform
iCardiac Technologies has announced the launch of its new eCOA platform, QPoint.
Advertisement
iCardiac Technologies has announced the launch of its new eCOA platform, QPoint. This platform looks to answer the growing demand for more efficient and innovative eCOA study services in drug development.
Read the full release
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
.png "BioPharm International")
.png "Pharmaceutical Commerce"){kind=logo}
.png "Turbo Machinery Magazine")
.png){kind=spacer}
